Aparaajita Balaji
InvestorAssociate at Longwood Fund
About
Aparaajita Balaji joined Longwood Fund's investment team in 2026, working across venture investing, company formation, and scientific research spanning multiple therapeutic areas and modalities. Before Longwood, she was an investor at KB Investment, leading diligence on companies from early discovery through late-stage programs, and previously served as a Healthcare Analyst Fellow at Canaan during her doctoral studies. She holds a Ph.D. in Molecular, Cellular, and Developmental Biology from Yale University and a B.A. in Molecular and Cell Biology: Genetics from UC Berkeley.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
Aculys PharmaBright Peak TherapeuticsCartography BiosciencesCHARM TherapeuticsCrystalys TherapeuticsNuvig TherapeuticsPathalys Pharma
Per the firm's website.
Colleagues at Longwood Fund
Frequently asked questions
- Who is Aparaajita Balaji?
- Aparaajita Balaji joined Longwood Fund's investment team in 2026, working across venture investing, company formation, and scientific research spanning multiple therapeutic areas and modalities. Before Longwood, she was an investor at KB Investment, leading diligence on companies from early discovery through late-stage programs, and previously served as a Healthcare Analyst Fellow at Canaan during her doctoral studies. She holds a Ph.D. in Molecular, Cellular, and Developmental Biology from Yale University and a B.A. in Molecular and Cell Biology: Genetics from UC Berkeley.
- Where does Aparaajita Balaji work?
- Aparaajita Balaji is Associate at Longwood Fund.
- What does Aparaajita Balaji invest in?
- Aparaajita Balaji invests in Biotech.
- What companies has Aparaajita Balaji invested in?
- Investments tracked here include Aculys Pharma, Bright Peak Therapeutics, Cartography Biosciences, CHARM Therapeutics, Crystalys Therapeutics, Nuvig Therapeutics, Pathalys Pharma.